5 Key Takeaways

• 1

  The FDA has approved the TECNIS PureSee IOL, an extended depth of focus intraocular lens for cataract surgery.

• 2

  TECNIS PureSee IOL will be available to US patients later this year, enhancing vision restoration opportunities.

• 3

  This IOL addresses cataract-related vision loss and presbyopia in a single surgical procedure.

• 4

  It is the first FDA-approved EDOF IOL with no warning on loss of contrast sensitivity, maintaining visual clarity.

• 5

  97% of patients report minimal visual disturbances post-surgery, reducing their reliance on glasses.